Profile of alisporivir and its potential in the treatment of hepatitis C

Two classes of hepatitis C antiviral agents currently exist, ie, direct-acting antivirals and host-targeting antivirals. Direct-acting antivirals target viral proteins including NS3/NS4A protease, NS5B polymerase and NS5A protein, while host-targeting antivirals target various host proteins critical...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallay, Philippe A, Lin, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578503/
https://www.ncbi.nlm.nih.gov/pubmed/23440335
http://dx.doi.org/10.2147/DDDT.S30946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578503/
https://www.ncbi.nlm.nih.gov/pubmed/23440335
http://dx.doi.org/10.2147/DDDT.S30946

Ejemplares similares